Annual Total Expenses
$25.03 M
+$4.33 M+20.93%
December 31, 2023
Summary
- As of February 8, 2025, ONCY annual total expenses is $25.03 million, with the most recent change of +$4.33 million (+20.93%) on December 31, 2023.
- During the last 3 years, ONCY annual total expenses has risen by +$6.02 million (+31.70%).
- ONCY annual total expenses is now -31.81% below its all-time high of $36.70 million, reached on December 31, 2012.
Performance
ONCY Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$7.25 M
+$1.47 M+25.36%
September 30, 2024
Summary
- As of February 8, 2025, ONCY quarterly total expenses is $7.25 million, with the most recent change of +$1.47 million (+25.36%) on September 30, 2024.
- Over the past year, ONCY quarterly total expenses has dropped by -$978.40 thousand (-11.88%).
- ONCY quarterly total expenses is now -36.73% below its all-time high of $11.46 million, reached on December 31, 2011.
Performance
ONCY Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ONCY Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +20.9% | -11.9% |
3 y3 years | +31.7% | +15.8% |
5 y5 years | +87.8% | +15.8% |
ONCY Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +20.9% | -11.9% | +56.3% |
5 y | 5-year | at high | +63.0% | -11.9% | +81.3% |
alltime | all time | -31.8% | +6339.9% | -36.7% | +2477.8% |
Oncolytics Biotech Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $7.25 M(+25.4%) |
Jun 2024 | - | $5.79 M(-10.6%) |
Mar 2024 | - | $6.47 M(-0.5%) |
Dec 2023 | $25.03 M(+20.9%) | $6.50 M(-21.0%) |
Sep 2023 | - | $8.23 M(+54.7%) |
Jun 2023 | - | $5.32 M(+6.9%) |
Mar 2023 | - | $4.98 M(-20.5%) |
Dec 2022 | $20.69 M(-1.1%) | $6.26 M(+35.0%) |
Sep 2022 | - | $4.64 M(-1.9%) |
Jun 2022 | - | $4.73 M(-5.0%) |
Mar 2022 | - | $4.98 M(-15.8%) |
Dec 2021 | $20.93 M(+10.1%) | $5.91 M(+21.0%) |
Sep 2021 | - | $4.89 M(-10.7%) |
Jun 2021 | - | $5.48 M(+17.6%) |
Mar 2021 | - | $4.66 M(-24.8%) |
Dec 2020 | $19.00 M(+23.8%) | $6.19 M(+30.7%) |
Sep 2020 | - | $4.74 M(+18.4%) |
Jun 2020 | - | $4.00 M(-2.8%) |
Mar 2020 | - | $4.12 M(-20.4%) |
Dec 2019 | $15.35 M(+15.2%) | $5.17 M(+95.6%) |
Sep 2019 | - | $2.64 M(-32.1%) |
Jun 2019 | - | $3.89 M(+6.9%) |
Mar 2019 | - | $3.64 M(-12.3%) |
Dec 2018 | $13.33 M(+10.7%) | $4.15 M(+59.8%) |
Sep 2018 | - | $2.60 M(-9.0%) |
Jun 2018 | - | $2.85 M(-23.2%) |
Mar 2018 | - | $3.72 M(+2.0%) |
Dec 2017 | $12.04 M(+4.3%) | $3.65 M(+50.5%) |
Sep 2017 | - | $2.42 M(-25.3%) |
Jun 2017 | - | $3.24 M(+20.4%) |
Mar 2017 | - | $2.69 M(-31.2%) |
Dec 2016 | $11.55 M(+5.9%) | $3.92 M(+51.9%) |
Sep 2016 | - | $2.58 M(+27.0%) |
Jun 2016 | - | $2.03 M(-31.8%) |
Mar 2016 | - | $2.98 M(+12.5%) |
Dec 2015 | $10.90 M(-36.0%) | $2.65 M(+20.2%) |
Sep 2015 | - | $2.20 M(-30.5%) |
Jun 2015 | - | $3.17 M(+8.7%) |
Mar 2015 | - | $2.91 M(-13.1%) |
Dec 2014 | $17.05 M(-26.5%) | $3.35 M(-22.0%) |
Sep 2014 | - | $4.30 M(-1.6%) |
Jun 2014 | - | $4.37 M(-13.6%) |
Mar 2014 | - | $5.05 M(-9.6%) |
Dec 2013 | $23.21 M(-36.8%) | $5.59 M(-6.7%) |
Sep 2013 | - | $5.99 M(+19.6%) |
Jun 2013 | - | $5.01 M(-24.5%) |
Mar 2013 | - | $6.63 M(-22.9%) |
Dec 2012 | $36.70 M | $8.60 M(-7.9%) |
Sep 2012 | - | $9.34 M(-8.2%) |
Jun 2012 | - | $10.17 M(+18.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2012 | - | $8.56 M(-25.3%) |
Dec 2011 | $29.05 M(+50.7%) | $11.46 M(+77.2%) |
Sep 2011 | - | $6.47 M(-4.4%) |
Jun 2011 | - | $6.77 M(+62.9%) |
Mar 2011 | - | $4.16 M(-43.7%) |
Dec 2010 | $19.28 M(+34.9%) | $7.38 M(+90.8%) |
Sep 2010 | - | $3.87 M(-9.3%) |
Jun 2010 | - | $4.26 M(+10.7%) |
Mar 2010 | - | $3.85 M(-22.2%) |
Dec 2009 | $14.30 M(-16.0%) | $4.95 M(+101.2%) |
Sep 2009 | - | $2.46 M(-34.0%) |
Jun 2009 | - | $3.73 M(+16.5%) |
Mar 2009 | - | $3.20 M(-19.6%) |
Dec 2008 | $17.02 M(+8.0%) | $3.98 M(-2.4%) |
Sep 2008 | - | $4.07 M(-25.0%) |
Jun 2008 | - | $5.43 M(+56.3%) |
Mar 2008 | - | $3.48 M(-16.3%) |
Dec 2007 | $15.76 M(+15.3%) | $4.15 M(+6.2%) |
Sep 2007 | - | $3.91 M(+2.0%) |
Jun 2007 | - | $3.83 M(+2.4%) |
Mar 2007 | - | $3.74 M(-17.0%) |
Dec 2006 | $13.66 M(+24.3%) | $4.51 M(+35.2%) |
Sep 2006 | - | $3.34 M(+12.7%) |
Jun 2006 | - | $2.96 M(+3.7%) |
Mar 2006 | - | $2.85 M(-17.1%) |
Dec 2005 | $10.99 M(+7.1%) | $3.44 M(+14.3%) |
Sep 2005 | - | $3.01 M(+23.5%) |
Jun 2005 | - | $2.44 M(+14.8%) |
Mar 2005 | - | $2.13 M(+42.5%) |
Dec 2004 | $10.26 M(+107.0%) | $1.49 M(-49.1%) |
Sep 2004 | - | $2.93 M(+21.9%) |
Jun 2004 | - | $2.40 M(+11.6%) |
Mar 2004 | - | $2.15 M(+37.8%) |
Dec 2003 | $4.96 M(+11.8%) | $1.56 M(+12.1%) |
Sep 2003 | - | $1.39 M(+8.5%) |
Jun 2003 | - | $1.28 M(+67.7%) |
Mar 2003 | - | $765.90 K(-31.7%) |
Dec 2002 | $4.43 M(-3.8%) | $1.12 M(-20.8%) |
Sep 2002 | - | $1.42 M(+47.1%) |
Jun 2002 | - | $962.80 K(+2.9%) |
Mar 2002 | - | $936.00 K(-11.6%) |
Dec 2001 | $4.61 M(+38.1%) | $1.06 M(-37.9%) |
Sep 2001 | - | $1.71 M(+67.5%) |
Jun 2001 | - | $1.02 M(+23.4%) |
Mar 2001 | - | $825.00 K(+8.1%) |
Dec 2000 | $3.34 M(+758.9%) | $763.50 K(-38.6%) |
Sep 2000 | - | $1.24 M(+19.5%) |
Jun 2000 | - | $1.04 M(+269.7%) |
Mar 2000 | - | $281.40 K |
Dec 1999 | $388.60 K | - |
FAQ
- What is Oncolytics Biotech annual total expenses?
- What is the all time high annual total expenses for Oncolytics Biotech?
- What is Oncolytics Biotech annual total expenses year-on-year change?
- What is Oncolytics Biotech quarterly total expenses?
- What is the all time high quarterly total expenses for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly total expenses year-on-year change?
What is Oncolytics Biotech annual total expenses?
The current annual total expenses of ONCY is $25.03 M
What is the all time high annual total expenses for Oncolytics Biotech?
Oncolytics Biotech all-time high annual total expenses is $36.70 M
What is Oncolytics Biotech annual total expenses year-on-year change?
Over the past year, ONCY annual total expenses has changed by +$4.33 M (+20.93%)
What is Oncolytics Biotech quarterly total expenses?
The current quarterly total expenses of ONCY is $7.25 M
What is the all time high quarterly total expenses for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly total expenses is $11.46 M
What is Oncolytics Biotech quarterly total expenses year-on-year change?
Over the past year, ONCY quarterly total expenses has changed by -$978.40 K (-11.88%)